When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TAK - Takeda's Approval And Other News: The Good Bad And Ugly Of Biopharma
Takeda Pharmaceutical Company Limited American Depositary Shares
Takeda Receives FDA Approval for Brigatinib
Takeda Pharmaceutical Company Limited (TAK) announced that the FDA has given a green signal for its ALUNBRIG (Brigatinib) in adult patients suffering from anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer. The label expansion allows the drug to be used in first line setting.
The FDA approval is based on the data obtained from Phase 3 ALTA 1L trial, which aimed to assess the safety and efficacy of ALUNBRIG compared to crizotinib in adult patients. The participants had ALK+ locally advanced or metastatic NSCLC who have